Behavioral neurocardiac training in hypertension: A randomized, controlled trial

Hypertension

Volumn 55, Issue 4, 2010, Pages 1033-1039

  Nolan, Robert P ^a   Floras, John S ^a   Harvey, Paula J ^a   Kamath, Markad V ^b   Picton, Peter E ^a   Chessex, Caroline ^a   Hiscock, Natalie ^c   Powell, Jonathan ^c   Catt, Michael ^c   Hendrickx, Hilde ^c   Talbot, Duncan ^c   Chen, Maggie H ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNILEVER RESEARCH   (United Kingdom)

Author keywords

Baroreflex; Biofeedback; Clinical trials; Heart rate variability; Hypertension; Relaxation; Stress

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BEHAVIOR THERAPY; BEHAVIORAL NEUROCARDIAC TRAINING; BLOOD PRESSURE MONITORING; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEEDBACK SYSTEM; FEMALE; HEART RATE VARIABILITY; HOME CARE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; MENTAL TASK; NEUROMODULATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; RELAXATION TRAINING; SENSITIVITY ANALYSIS; THERAPY EFFECT; ANALYSIS OF VARIANCE; BLOOD PRESSURE; CHI SQUARE DISTRIBUTION; COGNITIVE THERAPY; HEART RATE; HOSPITALIZATION; INTENTION TO TREAT ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESSORECEPTOR REFLEX; PSYCHOPHYSIOLOGY; REGRESSION ANALYSIS; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; BAROREFLEX; BIOFEEDBACK, PSYCHOLOGY; BLOOD PRESSURE; CHI-SQUARE DISTRIBUTION; COGNITIVE THERAPY; FEMALE; HEART RATE; HUMANS; HYPERTENSION; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 77950499370     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.146233     Document Type: Article

References (27)

1. Patel C, North WR. Randomised controlled trial of yoga and bio-feedback in management of hypertension. Lancet. 1975;2:93-95.
2. Alam GM, Smirk FH. Casual and basal blood pressures II: in essential hypertension. Br Heart J. 1943;5:156-160.
3. Benson H, Rosner BA, Marzetta BR, Klemchuk HM. Decreased blood-pressure in pharmacologically treated hypertensive patients who regularly elicited the relaxation response. Lancet. 1974;1:289-291.
4. Pickering T. Letter: yoga and bio-feedback in hypertension. Lancet. 1973;2:1440-1441.
5. Dickinson HO, Campbell F, Beyer FR, Nicolson DJ, Cook JV, Ford GA, Mason JM. Relaxation therapies for the management of primary hypertension in adults. Cochrane Database Syst Rev. 2008;(1):CD004935.
6. Nakao M, Yano E, Nomura S, Kuboki T. Blood pressure-lowering effects of biofeedback treatment in hypertension: a meta-analysis of randomized controlled trials. Hypertens Res. 2003;26:37-46.
7. Nolan RP, Kamath MV, Floras JS, Stanley J, Pang C, Picton P, Young QR. Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control. Am Heart J. 2005;149:1137.
8. Padwal RS, Hemmelgarn BR, McAlister FA, McKay DW, Grover S, Wilson T, Penner B, Burgess E, Bolli P, Hill M, Mahon J, Myers MG, Abbott C, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Cloutier L, Chockalingam A, Khan NA, Rabkin SW, Dawes M, Touyz RM, Tobe SW. The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1-blood pressure measurement, diagnosis and assessment of risk. Can J Cardiol. 2007;23:529-538.
9. Butler GC, Senn BL, Floras JS. Influence of atrial natriuretic factor on spontaneous baroreflex sensitivity for heart rate in humans. Hypertension. 1995;25:1167-1171
10. Center for the Study of Emotion and Attention-National Institute of Mental Health. International Affective Picture System (IAPS): Technical Manual and Affective Ratings. Gainesville, FL: NIMH-Center for the Study of Emotion and Attention, University of Florida; 1999.
11. Wiens AN, Fuller KH, Crossen JR. Paced Auditory Serial Addition Test: adult norms and moderator variables. J Clin Exp Neuropsychol. 1997;19: 473-483.
12. Whalen PJ, Bush G, McNally RJ, Wilhelm S, McInerney SC, Jenike MA, Rauch SL. The emotional counting Stroop paradigm: a functional magnetic resonance imaging probe of the anterior cingulate affective division. Biol Psychiatry. 1998;44:1219-1228.
13. Rochon J. Sample size calculations for two-group repeated-measures experiments. Biometrics. 1991;47:1383-1398.
14. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42: 1206-1252. (Pubitemid 37553153)
15. Blanchard EB, Miller ST, Abel GG, Haynes MR, Wicker R. Evaluation of biofeedback in the treatment of borderline essential hypertension. J Appl Behav Anal. 1979;12:99-109.
16. Frankel BL, Patel DJ, Horwitz D, Friedewald WT, Gaarder KR. Treatment of hypertension with biofeedback and relaxation techniques. Psychosom Med. 1978;40:276-293.
17. Irvine MJ, Johnston DW, Jenner DA, Marie GV. Relaxation and stress management in the treatment of essential hypertension. J Psychosom Res. 1986;30:437-450.
18. Jacob RG, Shapiro AP, O'Hara P, Portser S, Kruger A, Gatsonis C, Ding Y. Relaxation therapy for hypertension: setting-specific effects. Psychosom Med. 1992;54:87-101.
19. Hafner RJ. Psychological treatment of essential hypertension: a controlled comparison of meditation and meditation plus biofeedback. Biofeedback Self Regul. 1982;7:305-316.
20. Jurek IE, Higgins JT Jr, McGrady A. Interaction of biofeedback-assisted relaxation and diuretic in treatment of essential hypertension. Biofeedback Self Regul. 1992;17:125-141.
21. Floras JS, Hassan MO, Jones JV, Osikowska BA, Sever PS, Sleight P. Factors influencing blood pressure and heart rate variability in hypertensive humans. Hypertension. 1988;11:273-281.
22. Floras JS, Hassan MO, Jones JV, Osikowska BA, Sever PS, Sleight P. Consequences of impaired arterial baroreflexes in essential hypertension: effects on pressor responses, plasma noradrenaline and blood pressure variability. J Hypertens. 1988;6:525-535.
23. Nolan RP, Jong P, Barry-Bianchi SM, Tanaka TH, Floras JS. Effects of drug, biobehavioral and exercise therapies on heart rate variability in coronary artery disease: a systematic review. Eur J Cardiovasc Prev Rehabil. 2008;15:386-396.
24. La Rovere MT, Bersano C, Gnemmi M, Specchia G, Schwartz PJ. Exercise-induced increase in baroreflex sensitivity predicts improved prognosis after myocardial infarction. Circulation. 2002;106:945-949.
25. Lampert R, Ickovics JR, Viscoli CJ, Horwitz RI, Lee FA. Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the β-Blocker Heart Attack Trial. Am J Cardiol. 2003;91:137-142.
26. Collier D, Davies L, Bernardi L, Sleight P, Shiel J, Patel N, Misra S, Martin T, Moore D, Fok H, Scott B, David C, Caulfield M. Baroreceptor function changes with differing blood pressure treatment during the Anglo-Scandanavian Cardiac Outcomes Trial: principal results from the cardiac autonomic reflex assessment trial (CARAT). J Hypertens. 2006; 25:S292.
27. Kubo T, Parker JD, Azevedo ER, Atchison DJ, Newton GE, Picton P, Floras JS. Vagal heart rate responses to chronic β-blockade in human heart failure relate to cardiac norepinephrine spillover. Eur J Heart Fail. 2005;7:878-881.